Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer. Issue 2 (August 2015)
- Record Type:
- Journal Article
- Title:
- Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer. Issue 2 (August 2015)
- Main Title:
- Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer
- Authors:
- Trip, Anouk Kirsten
Sikorska, Karolina
van Sandick, Johanna W.
Heeg, Maarten
Cats, Annemieke
Boot, Henk
Jansen, Edwin Petrus Marianus
Verheij, Marcel - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">Abdominal (chemo-)radiotherapy is associated with dose-limiting toxicity of various normal structures. The purpose of this retrospective study was to investigate radiation-induced changes of the spleen and their clinical consequences.</p> </sec> <sec> <title id="st015">Patients and methods</title> <p id="sp0010">In gastric cancer patients treated with postoperative chemoradiotherapy, the spleen size and its functions were assessed at follow-up by spleen volume on CT-scan, serum leucocytes/thrombocytes, and the occurrence of infectious events consisting of pneumonia and fatal sepsis. To evaluate the effect of radiation dose, mixed effects and Cox regression models were used.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Forty-six out of 90 consecutive patients treated from 2006 to 2011 were evaluable. All patients received 45 Gy in 25 fractions with concurrent capecitabine (<italic>n</italic> = 8), and capecitabine/cisplatin (<italic>n</italic> = 38). Median Dmean to the spleen was 40 Gy (range 32–46). Mean relative spleen volume reduced to 37% (95% CI 32–42%) at 4-year follow-up, which was most strongly associated to the V44 (<italic>p</italic> &lt; 0.001). Median follow-up time was 67 (95% CI 57–78) months. Eleven patients had 13 pneumonias and 3 fatal sepsis. No association with dosimetric<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Background and purpose</title> <p id="sp0005">Abdominal (chemo-)radiotherapy is associated with dose-limiting toxicity of various normal structures. The purpose of this retrospective study was to investigate radiation-induced changes of the spleen and their clinical consequences.</p> </sec> <sec> <title id="st015">Patients and methods</title> <p id="sp0010">In gastric cancer patients treated with postoperative chemoradiotherapy, the spleen size and its functions were assessed at follow-up by spleen volume on CT-scan, serum leucocytes/thrombocytes, and the occurrence of infectious events consisting of pneumonia and fatal sepsis. To evaluate the effect of radiation dose, mixed effects and Cox regression models were used.</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">Forty-six out of 90 consecutive patients treated from 2006 to 2011 were evaluable. All patients received 45 Gy in 25 fractions with concurrent capecitabine (<italic>n</italic> = 8), and capecitabine/cisplatin (<italic>n</italic> = 38). Median Dmean to the spleen was 40 Gy (range 32–46). Mean relative spleen volume reduced to 37% (95% CI 32–42%) at 4-year follow-up, which was most strongly associated to the V44 (<italic>p</italic> &lt; 0.001). Median follow-up time was 67 (95% CI 57–78) months. Eleven patients had 13 pneumonias and 3 fatal sepsis. No association with dosimetric parameters was observed.</p> </sec> <sec> <title id="st025">Conclusions</title> <p id="sp0020">In postoperative chemoradiotherapy for gastric cancer, the spleen received a high radiation dose. This resulted in a progressive, radiation dose-dependent reduction of spleen volume. Pneumonia and fatal sepsis occurred frequently, possibly as a result of functional hyposplenia.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 116:Issue 2(2015:Aug.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 116:Issue 2(2015:Aug.)
- Issue Display:
- Volume 116, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 116
- Issue:
- 2
- Issue Sort Value:
- 2015-0116-0002-0000
- Page Start:
- 239
- Page End:
- 244
- Publication Date:
- 2015-08
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.07.036 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3937.xml